Evaluation of renal masses with contrast-enhanced ultrasound

Current Urology Reports

Volumn 14, Issue 2, 2013, Pages 116-123

  Houtzager, S ^a   Wijkstra, H ^a   De La Rosette, J J M C H ^a   Laguna, M P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Ablation therapy; Contrast enhanced ultrasound; Kidney; Renal cancer; Small renal mass; Ultrasound contrast agent

Indexed keywords

GADOLINIUM; IODINE;

ANGIOMYOLIPOMA; ARTICLE; BENIGN TUMOR; CONTRAST ENHANCEMENT; CRYOABLATION; ECHOGRAPHY; HUMAN; IONIZING RADIATION; KIDNEY BLOOD FLOW; KIDNEY CANCER; KIDNEY CYST; KIDNEY MASS; MALIGNANT NEOPLASTIC DISEASE; MICROBUBBLE; MINIMALLY INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOCYTOMA; PSEUDOTUMOR; RADIOFREQUENCY ABLATION; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADENOMA, OXYPHILIC; ANGIOMYOLIPOMA; CARCINOMA, RENAL CELL; CATHETER ABLATION; CONTRAST MEDIA; CRYOSURGERY; CYSTS; HUMANS; KIDNEY DISEASES; KIDNEY NEOPLASMS; MICROBUBBLES;

EID: 84879607099     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-013-0309-x     Document Type: Article

References (62)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10-29.
2. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008;113:78-83.
3. Nepple KG, Yang L, Grubb III RL, Strope SA. Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006. J Urol. 2012;187:32-8.
4. Israel GM, Bosniak MA. Pitfalls in renal mass evaluation and how to avoid them. Radiographics. 2008;28:1325-38.
5. Millet I, Doyon FC, Hoa D, Thuret R, Merigeaud S, Serre I, et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol. 2011;197:887-96.
6. Kummerlin I, ten KF, Smedts F, Horn T, Algaba F, Trias I, et al. Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur Urol. 2008;53:1219-25.
7. Leveridge MJ, Finelli A, Kachura JR, Evans A, Chung H, Shiff DA, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60:578-84.
8. Menogue SR, O'Brien BA, Brown AL, Cohen RJ. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. BJU Int 2012.
9. Sofikerim M, Tatlisen A, Canoz O, Tokat F, Demirtas A, Mavili E. What is the role of percutaneous needle core biopsy in diagnosis of renal masses? Urology. 2010;76:614-8.
10. Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy-a renaissance? J Urol. 2008;179:20-7.
11. Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol. 2012;62:491-504.
12. • Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217-20. This article provides a good overview of the figures concerning the distribution of benign and malignant renal masses and the involved treatments.
13. • Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol. 2006;175:2027-31. This article reports the amount of unnecessary surgery peformed in exist SRMs of benign origin after surgery in a large study cohort.
14. Weisbord SD, Palevsky PM. Strategies for the prevention of contrast-induced acute kidney injury. Curr Opin Nephrol Hypertens. 2010;19:539-49.
15. Azmin M, Harfield C, Ahmad Z, Edirisinghe M, Stride E. How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles. Curr Pharm Des. 2012;18:2118-34.
16. Liu Y, Miyoshi H, Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Contr Release. 2006;114:89-99.
17. Wilson SR, Burns PN. Microbubble-enhanced US in body imaging: what role? Radiology. 2010;257:24-39.
18. Wei K, Le E, Bin JP, Coggins M, Thorpe J, Kaul S. Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol. 2001;37:1135-40.
19. • Blomley M, Claudon M, Cosgrove D. WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns. Ultrasound Med Biol. 2007;33:180-6. This article describes the safety of CEUS.
20. • Piscaglia F, Nolsoe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann NM, et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33:33-59. This article describes the current guidelines and recommendations for the use of CEUS.
21. Murphy AM, Buck AM, Benson MC, McKiernan JM. Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology. 2009;73:1293-7.
22. Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181:2033-6.
23. Tsivian M, Mouraviev V, Albala DM, Caso JR, Robertson CN, Madden JF, et al. Clinical predictors of renal mass pathological features. BJU Int. 2011;107:735-40.
24. Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol. 2003;58:626-9.
25. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006;49:798-805.
26. Lopez-Beltran A, Carrasco JC, Cheng L, Scarpelli M, Kirkali Z, Montironi R. 2009 update on the classification of renal epithelial tumors in adults. Int J Urol. 2009;16:432-43.
27. Kawaguchi S, Fernandes KA, Finelli A, Robinette M, Fleshner N, Jewett MA. Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance. J Urol. 2011;186:1218-22.
28. Lhermitte B, de Leval L. Interpretation of needle biopsies of the kidney for investigation of renal masses. Virchows Arch. 2012;461:13-26.
29. Fan L, Lianfang D, Jinfang X, Yijin S, Ying W. Diagnostic efficacy of contrast-enhanced ultrasonography in solid renal parenchymal lesions with maximum diameters of 5 cm. J Ultrasound Med. 2008;27:875-85.
30. Haendl T, Strobel D, Legal W, Frieser M, Hahn EG, Bernatik T. Renal cell cancer does not show a typical perfusion pattern in contrast-enhanced ultrasound. Ultraschall Med. 2009;30:58-63.
31. Tamai H, Takiguchi Y, Oka M, Shingaki N, Enomoto S, Shiraki T, et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med. 2005;24:1635-40.
32. Lane BR, Aydin H, Danforth TL, Zhou M, Remer EM, Novick AC, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol. 2008;180:836-43.
33. Xu ZF, Xu HX, Xie XY, Liu GJ, Zheng YL, Lu MD. Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med. 2010;29:709-17.
34. Lu Q, Wang W, Huang B, Li C, Li C. Minimal Fat Renal Angiomyolipoma: the initial study with contrast-enhanced ultrasonography. Ultrasound Med Biol 2012;38:1896-901.
35. Bosniak MA. The Bosniak renal cyst classification: 25 years later. Radiology. 2012;262:781-5.
36. Smith AD, Remer EM, Cox KL, Lieber ML, Allen BC, Shah SN, et al. Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology. 2012;262:152-60.
37. Weibl P, Klatte T, Kollarik B, Waldert M, Schuller G, Geryk B, et al. Interpersonal variability and present diagnostic dilemmas in Bosniak classification system. Scand J Urol Nephrol. 2011;45:239-44.
38. Aoki S, Hattori R, Yamamoto T, Funahashi Y, Matsukawa Y, Gotoh M, et al. Contrast-enhanced ultrasound using a time-intensity curve for the diagnosis of renal cell carcinoma. BJU Int. 2011;108:349-54.
39. Park BK, Kim B, Kim SH, Ko K, Lee HM, Choi HY. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol. 2007;61:310-4.
40. Clevert DA, Minaifar N, Weckbach S, Jung EM, Stock K, Reiser M, et al. Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system. Clin Hemorheol Microcirc. 2008;39:171-8.
41. Bhatt S, MacLennan G, Dogra V. Renal pseudotumors. AJR Am J Roentgenol. 2007;188:1380-7.
42. Ascenti G, Zimbaro G, Mazziotti S, Gaeta M, Lamberto S, Scribano E. Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol. 2001;11:2496-9.
43. Jinzaki M, Ohkuma K, Tanimoto A, Mukai M, Hiramatsu K, Murai M, et al. Small solid renal lesions: usefulness of power Doppler US. Radiology. 1998;209:543-50.
44. Mazziotti S, Zimbaro F, Pandolfo A, Racchiusa S, Settineri N, Ascenti G. Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging. 2010;35:241-5.
45. Zhang C, Li X, Hao H, Yu W, He Z, Zhou L. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases. BJU Int 2012.
46. Jiang J, Chen Y, Zhou Y, Zhang H. Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size. Eur J Radiol. 2010;73:162-7.
47. Xu ZF, Xu HX, Xie XY, Liu GJ, Zheng YL, Liang JY, et al. Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging. 2010;35:750-6.
48. Gerst S, Hann LE, Li D, Gonen M, Tickoo S, Sohn MJ, et al. Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. AJR Am J Roentgenol. 2011;197:897-906.
49. Ignee A, Straub B, Brix D, Schuessler G, Ott M, Dietrich CF. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc. 2010;46:275-90.
50. Mouraviev V, Joniau S, Van PH, Polascik TJ. Current status of minimally invasive ablative techniques in the treatment of small renal tumours. Eur Urol. 2007;51:328-36.
51. Zhao X, Wang W, Zhang S, Liu J, Zhang F, Ji C, et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging. 2012;37:885-91.
52. Johnson DB, Duchene DA, Taylor GD, Pearle MS, Cadeddu JA. Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imaging of the thermolesion. J Endourol. 2005;19:248-52.
53. Slabaugh TK, Machaidze Z, Hennigar R, Ogan K. Monitoring radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: a porcine model. J Endourol. 2005;19:579-83.
54. Hoeffel C, Pousset M, Timsit MO, Elie C, Mejean A, Merran S, et al. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol. 2010;20:1812-21.
55. Meloni MF, Bertolotto M, Alberzoni C, Lazzaroni S, Filice C, Livraghi T, et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol. 2008;191:1233-8.
56. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol. 2007;189:429-36.
57. Wink MH, Laguna MP, Lagerveld BW, de la Rosette JJ, Wijkstra H. Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal tumours: a feasibility study. BJU Int. 2007;99:1371-5.
58. Phillips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol. 2004;14 Suppl 8:4-10.
59. Stieger SM, Dayton PA, Borden MA, Caskey CF, Griffey SM, Wisner ER, et al. Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging. 2008;3:9-18.
60. Barwari K, Wijkstra H, van Delden OM, de la Rosette J, Laguna P. Contrast-enhanced ultrasound for the evaluation of the cryolesion after laparoscopic renal cryoablation: an initial report. J Endourol 2012. doi: 10.1089/end.2012.0400.
61. Yin T, Wang P, Zheng R, Zheng B, Cheng D, Zhang X, et al. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine. 2012;7:895-904.
62. Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol. 2009;193:55-60.